✦ LIBER ✦

Recent topics related to nephrogenic systemic fibrosis associated with gadolinium-based contrast agents

✍ Scribed by Kazuhiro Kitajima; Tetsuo Maeda; Sanae Watanabe; Yoshiko Ueno; Kazuro Sugimura

Book ID: 115177219
Publisher: John Wiley and Sons
Year: 2012
Tongue: English
Weight: 109 KB
Volume: 19
Category: Article
ISSN: 0919-8172
DOI: 10.1111/j.1442-2042.2012.03042.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Editorial Comment from Dr Ishii to Recen

Editorial Comment from Dr Ishii to Recent topics related to nephrogenic systemic fibrosis associated with gadolinium-based contrast agents

✍ Tokumi Ishii 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 67 KB

Editorial Comment from Dr Mori to Recent

Editorial Comment from Dr Mori to Recent topics related to nephrogenic systemic fibrosis associated with gadolinium-based contrast agents

✍ Harushi Mori 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB

Nephrogenic systemic fibrosis and the us

Nephrogenic systemic fibrosis and the use of gadolinium-based contrast agents

✍ Jeffrey G. Penfield 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 167 KB

Nephrogenic systemic fibrosis associated

Nephrogenic systemic fibrosis associated with gadolinium based contrast agents: A summary of the medical literature reporting

✍ Dale R. Broome 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 99 KB

Strong association between the use of ga

Strong association between the use of gadolinium-based contrast agents with nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis

✍ J. Jamboti 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 44 KB

Biochemical safety profiles of gadoliniu

Biochemical safety profiles of gadolinium-based extracellular contrast agents and nephrogenic systemic fibrosis

✍ Hale Ersoy; Frank J. Rybicki 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 100 KB

## Abstract Gadolinium (Gd)‐based paramagnetic contrast agents are relatively safe when used in clinically recommended doses. However, with the rapidly expanding body of literature linking Gd‐based paramagnetic contrast agents and nephrogenic systemic fibrosis (NSF), awareness of the potential side